Target intelligence / Profile preview

SRY-box transcription factor 9 mRNA 3' untranslated region (SOX9 mRNA 3'UTR)

Target
SOX9 mRNA 3'UTR
Molecular classification
RNA, Messenger RNA regulatory element
01

Overview

The SRY-box transcription factor 9 (SOX9) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the SOX9 transcript that governs protein expression through post-transcriptional mechanisms (NCBI Gene ID: 6662). SOX9 is a master transcription factor essential for chondrogenesis and male gonad development, but its overexpression is a hallmark of various cancers, including colorectal, breast, and lung carcinomas (UniProt: P48436). The 3'UTR serves as a scaffold for microRNAs (miRNAs) and RNA-binding proteins that modulate the stability and translation of the mRNA transcript. In many pathological states, the downregulation of tumor-suppressive miRNAs like miR-145 or miR-101 leads to the stabilization of SOX9 mRNA, driving epithelial-mesenchymal transition (EMT) and tumor progression (PubMed: 28651317). Therapeutic strategies targeting this region involve the use of miRNA mimics or antisense oligonucleotides (ASOs) to restore regulatory control and reduce SOX9 protein levels (PubMed: 30210156). This makes the SOX9 mRNA 3'UTR a significant focal point for the development of precision RNA-based therapeutics in oncology and regenerative medicine.

Other names
SOX9 3'UTR3' untranslated region of SRY-box 9 mRNASRY-box transcription factor 9 regulatory region
02

Mechanism of action

Binding of complementary RNA sequences or antisense oligonucleotides to the 3'UTR to induce mRNA degradation or translational repression via the RNA-induced silencing complex (RISC) (PubMed: 24510005).

03

Biological functions

Post-transcriptional gene regulationmRNA stability regulationTranslation inhibitionMicroRNA-mediated silencing
04

Disease associations

CancerFibrosisCampomelic dysplasiaOsteoarthritis
05

Safety considerations

Off-target hybridization to non-target mRNAsPotential for innate immune activation by synthetic RNAChallenges in tissue-specific delivery of RNA therapeuticsSaturation of the endogenous RNAi machinery
06

Interacting drugs

miR-145 mimics (experimental)

3 more in the full profile.

07

Biomarkers

SOX9 mRNA expression levelsSOX9 protein expression levelsmiR-145 expression levelsmiR-101 expression levels

Beyond the preview

Go deeper on SRY-box transcription factor 9 mRNA 3' untranslated region (SOX9 mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRY-box transcription factor 9 mRNA 3' untranslated region (SOX9 mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call